Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy
Abstract Despite significant clinical progress, checkpoint blockade remains limited by variable response rates, resistance, and toxicity. Activating costimulatory receptors offers a promising alternative to enhance anti-tumor immunity. However, there is insufficient understanding of how to mimic phy...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Nature Portfolio
2025-12-01
|
| Sraith: | Nature Communications |
| Rochtain ar líne: | https://doi.org/10.1038/s41467-025-67882-3 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|